1,4-Benzenediamine


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:22149045IVR2 mg/kg/day 2 mg/kg/dayDecreased testis weightsReproductive endocrine-mediated perturbations
IVR2 mg/kg/day 2 mg/kg/dayChanges in morphology of seminiferous tubulesReproductive endocrine-mediated perturbations
IVR2 mg/kg/day 2 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR2 mg/kg/day 2 mg/kg/dayIncrease in the number of abnormal spermsReproductive endocrine-mediated perturbations
IVR2 mg/kg/day 2 mg/kg/dayOxidative stress in testisReproductive endocrine-mediated perturbations
IVR3 mg/kg/day 3 mg/kg/dayChanges in morphology of seminiferous tubulesReproductive endocrine-mediated perturbations
IVR3 mg/kg/day 3 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR3 mg/kg/day 3 mg/kg/dayOxidative stress in testisReproductive endocrine-mediated perturbations
IVR3 mg/kg/day 3 mg/kg/dayDecreased testis weightsReproductive endocrine-mediated perturbations
IVR3 mg/kg/day 3 mg/kg/dayIncrease in the number of abnormal spermsReproductive endocrine-mediated perturbations
IVR1 mg/kg/day -No significant effects observed-

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.